Key Highlights

  • IQ Merger Arbitrage ETF (NYSEARCA:MNA) gained fresh deal flow on Monday, October 19, 2026, as Merck KGaA agreed to buy Silence Therapeutics (NASDAQ:SLN) for USD 20 per share, a 130% premium.
  • TTM Technologies (NASDAQ:TTMI) agreed the same day to buy the Ophir Optics business of MKS (NASDAQ:MKSI) for about USD 650 million in cash, while Hologic agreed to acquire Reveal Genomics on undisclosed terms.
  • A Breakingviews column on Tuesday, October 20 described the day as having old-economy vibes and cited Roche's pact with Hansoh worth up to USD 15 billion, a figure not checked against company releases.
  • The wave followed reports on Friday, October 16 that SoftBank was weighing a purchase of Allied Universal at an equity value of up to USD 18 billion, talks that remain preliminary.

What Was Announced on Monday

IQ Merger Arbitrage ETF (NYSEARCA:MNA) invests in companies that are targets of announced takeovers, so it depends on a steady supply of deals. Monday, October 19, 2026 provided several. Merck KGaA agreed to pay USD 20.00 in cash per American depositary share for Silence Therapeutics, a 130% premium and an equity value of about USD 1.3 billion. TTM Technologies agreed to buy Ophir Optics from MKS for about USD 650 million in cash, with closing expected in the second quarter of 2027. Hologic agreed to buy Reveal Genomics, a cancer genomic testing firm. Breakingviews also cited Roche's Hansoh pact of up to USD 15 billion, which is a licensing-style agreement rather than a takeover.

How Merger Arbitrage Earns Its Return

Merger arbitrage buys a target after a deal is announced and collects the spread, the gap between the market price and the offer, if the deal closes. For Silence Therapeutics, a 125% share gain against a 130% premium leaves a spread of about 2.2%, simple arithmetic on the published figures. That return is earned over the months to closing, expected in the first quarter of 2027. IQ Merger Arbitrage ETF (NYSEARCA:MNA) aggregates many such spreads, so its results depend on deal volume, spread width and how often deals fail. Higher short-term interest rates usually widen spreads, because investors demand at least the return on cash for the time and risk involved.

Risks and What to Watch

The first risk is deal failure. A broken deal can send a target back towards its pre-bid price, which for Silence would mean a level near USD 8.70, about 56% below the offer by simple arithmetic. The second risk is regulatory and timing risk: TTM's purchase needs certain regulatory approvals and is not expected to close until the second quarter of 2027. The third risk is financing, as credit investors remain cautious after the artificial intelligence debt scare. For IQ Merger Arbitrage ETF (NYSEARCA:MNA), investors should watch the Silence proxy timetable, any confirmation of the SoftBank talks and the Fed decision on Wednesday, October 28.

Where Things Stand

The answer is that Merger Monday added both new targets and a clear example of how spreads work, with Silence trading about 2.2% below a USD 20.00 cash offer. For IQ Merger Arbitrage ETF (NYSEARCA:MNA), more announced deals mean more spreads to capture, although holdings are set by the fund's index and were not checked here. The next catalysts are the Fed meeting on October 27 to 28, deal filings and any further Monday announcements. Deal spreads are not guaranteed returns, and this is not investment advice.